Order Article Reprints

Punganuru SR, Arutla V, Zhao W, Rajaei M, Deokar H, Zhang R, Buolamwini JK, Srivenugopal KS, Wang W. Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action. Cells. 2020; 9(7):1592. https://doi.org/10.3390/cells9071592

Punganuru, Surendra R., Viswanath Arutla, Wei Zhao, Mehrdad Rajaei, Hemantkumar Deokar, Ruiwen Zhang, John K. Buolamwini, Kalkunte S. Srivenugopal, and Wei Wang. 2020. "Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action" Cells 9, no. 7: 1592. https://doi.org/10.3390/cells9071592

Punganuru, S. R., Arutla, V., Zhao, W., Rajaei, M., Deokar, H., Zhang, R., Buolamwini, J. K., Srivenugopal, K. S., & Wang, W. (2020). Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action. Cells, 9(7), 1592. https://doi.org/10.3390/cells9071592